José M. Miró mainly focuses on Internal medicine, Endocarditis, Infective endocarditis, Surgery and Immunology. His Internal medicine study frequently draws connections to adjacent fields such as Acquired immunodeficiency syndrome. The concepts of his Endocarditis study are interwoven with issues in Bacteremia, Cardiac surgery, Staphylococcal infections and Microbiology.
His Infective endocarditis research integrates issues from Abscess, Heart disease, Heart failure and Intensive care medicine. In Surgery, José M. Miró works on issues like Epidemiology, which are connected to Mycosis. As a part of the same scientific family, José M. Miró mostly works in the field of Immunology, focusing on Gastroenterology and, on occasion, T lymphocyte.
Internal medicine, Endocarditis, Infective endocarditis, Immunology and Surgery are his primary areas of study. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Acquired immunodeficiency syndrome and Viral load. His Viral load research incorporates elements of Viral disease, Lentivirus and Regimen.
His Endocarditis course of study focuses on Vancomycin and Methicillin-resistant Staphylococcus aureus. His Infective endocarditis study combines topics from a wide range of disciplines, such as Cardiac surgery, Heart disease, Heart failure and Intensive care medicine. His work carried out in the field of Surgery brings together such families of science as Incidence and Cohort study.
His primary scientific interests are in Internal medicine, Infective endocarditis, Endocarditis, Prospective cohort study and Cohort. José M. Miró has researched Internal medicine in several fields, including Enterococcus faecalis, Antibiotics and Viral load. His work deals with themes such as Dolutegravir, Elvitegravir, Acquired immunodeficiency syndrome and Drug resistance, which intersect with Viral load.
His Infective endocarditis study necessitates a more in-depth grasp of Surgery. His Endocarditis research includes elements of Heart failure, Daptomycin, Medical microbiology, Microbiology and Ceftriaxone. His Microbiology study which covers Vancomycin that intersects with Methicillin Susceptible Staphylococcus Aureus and Etest.
His primary areas of investigation include Internal medicine, Endocarditis, Infective endocarditis, Epidemiology and Acquired immunodeficiency syndrome. His Endocarditis study incorporates themes from Medical microbiology, Prospective cohort study, Adverse effect and Retrospective cohort study. His work in Prospective cohort study addresses issues such as Heart failure, which are connected to fields such as Cardiac surgery, Proportional hazards model, Abscess, Surgery and Interquartile range.
His research integrates issues of Incidence, Cohort and Pneumonia in his study of Epidemiology. His study on Incidence also encompasses disciplines like
Cervical cancer that connect with fields like Cohort study and Hazard ratio,
Intensive care medicine most often made with reference to Community-acquired pneumonia. His research on Acquired immunodeficiency syndrome also deals with topics like
Pediatrics which intersects with area such as Clinical case, Hiv infected and Viral load,
Regimen which is related to area like Absolute risk reduction, Observational study, Marginal structural model and Protocol.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
2015 ESC Guidelines for the management of infective endocarditis
Gilbert Habib;Patrizio Lancellotti;Manuel J. Antunes;Maria Grazia Bongiorni.
European Heart Journal (2015)
Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century: The International Collaboration on Endocarditis-Prospective Cohort Study
David R. Murdoch;G. Ralph Corey;Bruno Hoen;José M. Miró.
JAMA Internal Medicine (2009)
A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1
Jacques Fellay;Kevin V. Shianna;Dongliang Ge;Sara Colombo.
Science (2007)
Staphylococcus aureus Endocarditis A Consequence of Medical Progress
Vance G. Fowler;Jose M. Miro;Bruno Hoen;Christopher H. Cabell.
JAMA (2005)
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
Jonathan A C Sterne;Margaret May;Dominique Costagliola;Frank de Wolf.
The Lancet (2009)
Common genetic variation and the control of HIV-1 in humans.
Jacques Fellay;Dongliang Ge;Kevin V. Shianna;Sara Colombo.
PLOS Genetics (2009)
2015 ESC Guidelines for the management of infective endocarditis
Gilbert Habib;Patrizio Lancellotti;Manuel J. Antunes;Maria Grazia Bongiorni.
Kardiologia Polska (2015)
Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis
Susan E. Dorman;John L. Johnson;Stefan Goldberg;Grace Muzanye.
American Journal of Respiratory and Critical Care Medicine (2009)
The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS).
Stuart A. Dickerman;Elias Abrutyn;Bruno Barsic;Emilio Bouza.
American Heart Journal (2007)
Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.
García F;Plana M;Vidal C;Cruceta A.
AIDS (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Barcelona
University of Barcelona
University of Barcelona
Duke University
Hospital General Universitario Gregorio Marañón
Duke University
Hospital General Universitario Gregorio Marañón
University College London
Hôpital de la Timone
University of California, Los Angeles
Aix-Marseille University
National Central University
Ansys (United States)
University of California, Berkeley
Nankai University
Shivaji University
REGENXBIO Inc.
Istituto Superiore di Sanità
Jinan University
University of North Carolina at Chapel Hill
Inserm : Institut national de la santé et de la recherche médicale
Carnegie Mellon University
University of Southern California
Mayo Clinic
University of Chile
University of Sheffield